EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids

Annelies Van Hemelryk iD, Sigrun Erkens-Schulze, Lifani Lim, Corrina M A de Ridder, Debra C Stuurman, Guido W Jenster iD, Martin E van Royen iD, Wytske M van Weerden iD

Cells · 2023

DOI: 10.3390/cells12101377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Annelies Van Hemelryk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor organoids have been pushed forward as advanced model systems for in vitro oncology drug testing, with the eventual goal to direct personalized cancer treatments. However, drug testing efforts suffer from a large variation in experimental conditions for organoid culturing and organoid treatment. Moreover, most drug tests are restricted to whole-well viability as the sole read-out, thereby losing important information about key biological aspects that might be impacted due to the use of administered drugs. These bulk read-outs also discard potential inter-organoid heterogeneity in drug responses. To tackle these issues, we developed a systematic approach for processing organoids from prostate cancer (PCa) patient-derived xenografts (PDXs) for viability-based drug testing and identified essential conditions and quality checks for consistent results. In addition, we generated an imaging-based drug testing procedure using high-content fluorescence microscopy in living PCa organoids to detect various modalities of cell death. Individual organoids and cell nuclei in organoids were segmented and quantified using a dye combination of Hoechst 33342, propidium iodide and Caspase 3/7 Green, allowing the identification of cytostatic and cytotoxic treatment effects. Our procedures provide important insights into the mechanistic actions of tested drugs. Moreover, these methods can be adapted for tumor organoids originating from other cancer types to increase organoid-based drug test validity, and ultimately, accelerate clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAntineoplastic AgentsMaleAnimalsHumansHeterograftsDisease Models, AnimalOrganoids

Stichwörter der Autor:innen

drug testinghigh-content screeninglive-cell confocal microscopyorganoidpatient-derived xenograftprostate cancerviability assays

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Department of Pathology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.

ORCID-Profile: Annelies Van Hemelryk, Guido W Jenster, Martin E van Royen, Wytske M van Weerden

Förderung

  • European Union’s Horizon 2020 research and innovation program

Zitieren

APA

Van Hemelryk, A., Erkens-Schulze, S., Lim, L., de Ridder, C. M. A., Stuurman, D. C., Jenster, G. W., van Royen, M. E., & van Weerden, W. M. (2023). Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids. Cells. https://doi.org/10.3390/cells12101377

Vancouver

Van Hemelryk A, Erkens-Schulze S, Lim L, de Ridder CMA, Stuurman DC, Jenster GW, et al. Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids. Cells. 2023. doi:10.3390/cells12101377

BibTeX
@article{VanHemelryk2023,
  author = {Van Hemelryk, Annelies and Erkens-Schulze, Sigrun and Lim, Lifani and de Ridder, Corrina M A and Stuurman, Debra C and Jenster, Guido W and van Royen, Martin E and van Weerden, Wytske M},
  title = {Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12101377}
}
Kostenlos starten →